In vitro activity of nadifloxacin against both methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus from patients with skin infections.
Division of Dermatology, Kansai Medical University, Osaka, Japan.
S
S
Nishijima
S
S
Namura
H
H
Akamatsu
S
S
Kawai
Y
Y
Asada
S
S
Kawabata
M
M
Fujita
D000890:Anti-Infective Agents / Q000494:pharmacology*; D024841:Fluoroquinolones; D006801:Humans; D016106:Methicillin Resistance / Q000502:physiology*; D011807:Quinolizines / Q000494:pharmacology*; D013207:Staphylococcal Skin Infections / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D011807:Quinolizines; C062127:nadifloxacin